BEKHealth

Overview
News
Clinical Trial Technology?
Product stageSegments
Go-to-Market
?
Patient and Outcome Data Management, Patient Recruitment
?

BEKHealth is a technology company that operates an artificial intelligence (AI)-powered patient-matching software platform serving the clinical trial industry. The company's platform leverages AI to rapidly sift through structured and unstructured electronic medical record (EMR) data, enabling life sciences and healthcare organizations to speed up site selection and patient recruitment processes. BEKHealth's platform accesses patient charts, including saved files, reports, and notes, and transforms the unstructured data using deep learning neural networks based on BERT to identify medical entities and associated attributes. The transformed text is mapped to a searchable ontology comprising over 24 million search terms, synonyms, and lexemes. Combined with structured medical data, the platform generates a synthesized, longitudinal patient graph. BEKHealth employs a human-in-the-loop feedback mechanism to ensure a high level of accuracy, achieving a 93% accuracy rate in interpreting EMR records as of April 2024. By sifting through structured data and translating handwritten notes and charts, BEKHealth's platform can identify clinically qualified patients for even the most rigorous inclusion and exclusion criteria, enabling faster and more accurate patient recruitment for clinical trials.

Key customers and partnerships

In July 2023, BEKHealth partnered with Alcanza Clinical Research, a mission-focused investigator site network, to leverage its AI-powered platform for participant identification and matching services. This collaboration aims to expand diverse representation and engage more patients with clinical research opportunities.

In November 2022, BEKHealth collaborated with Science 37, a virtual clinical trial site, enabling Science 37 to access EMR data across its network of over 35,000 community providers covering more than 35 million patient lives. This partnership aims to expand patient access to clinical trials, accelerate enrollment, and potentially reduce time to market for investigational treatments.

In February 2022, the company announced a partnership with CCT Research, a network of clinical research sites, to streamline access to EMR data across CCT's sites and drive a data-driven approach to trial execution and management. In July 2022, BEKHealth partnered with Western States Cancer Research NCORP to extend access and availability of oncology clinical trials to physicians and patients in Colorado, Washington state, and Alaska.

HQ location:
85 North Main Street #1028 Branford CT USA
Founded year:
2017
Employees:
11-50
IPO status:
Private
Total funding:
USD 14.7 mn
Last Funding:
USD 3.6 mn (Series Unknown; Sep 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.